Advertisement
Advertisement

OMER

OMER logo

Omeros Corporation

11.23
USD
Sponsored
+0.49
+4.61%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

11.14

-0.09
-0.80%

OMER Earnings Reports

Positive Surprise Ratio

OMER beat 29 of 40 last estimates.

73%

Next Report

Date of Next Report
Mar 03, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.58
Implied change from Q3 25 (Revenue/ EPS)
--
/
+23.40%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+7.41%

Omeros Corporation earnings per share and revenue

On Nov 13, 2025, OMER reported earnings of -0.47 USD per share (EPS) for Q3 25, missing the estimate of -0.45 USD, resulting in a -3.55% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +25.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.58 USD, with revenue projected to reach -- USD, implying an increase of 23.40% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
logo
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
logo
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
logo
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
logo
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
logo
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
logo
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
logo
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
logo
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
logo
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
FAQ
For Q3 2025, Omeros Corporation reported EPS of -$0.47, missing estimates by -3.55%, and revenue of $0.00, 0% as expectations.
The stock price moved up 25.32%, changed from $6.28 before the earnings release to $7.87 the day after.
The next earning report is scheduled for Mar 03, 2026.
Based on 6 analysts, Omeros Corporation is expected to report EPS of -$0.58 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement